key: cord-0908205-eeeou6f5
authors: Gonzales, Rex R.; Machamer, Carolyn E.
title: The SARS CoV-1 3a protein disrupts Golgi complex morphology and cargo trafficking
date: 2021-04-19
journal: bioRxiv
DOI: 10.1101/2021.04.19.440492
sha: c01d77c3afaadb7d2f9b68ba2015a9f559c274b5
doc_id: 908205
cord_uid: eeeou6f5

Coronaviruses assemble by budding into the endoplasmic reticulum-Golgi intermediate compartment, but the pathway of egress from infected cells is not well understood. Efficient egress of infectious bronchitis virus (a gamma coronavirus, CoV) requires neutralization of Golgi pH by the envelope (E) protein. This results in reduced rates of cargo traffic and disrupts Golgi morphology, but it protects the spike protein from aberrant proteolysis. The severe acute respiratory syndrome (SARS) CoV-1 E protein does not disrupt the Golgi, however. We show here that in transfected cells, the ORF3a protein of SARS CoV-1 disrupts Golgi morphology, cargo trafficking and luminal pH. Unlike the infectious bronchitis virus E protein, these functions of the SARS CoV-1 3a protein appear to require its viroporin activity. Thus, neutralization of acidic compartments may be a universal feature of CoV infection, although different viral proteins and mechanisms may be used to achieve this outcome.

Coronaviruses are enveloped RNA viruses that assemble by budding into the endoplasmic reticulum-Golgi intermediate compartment. The envelope proteins (spike, S; membrane, M and envelope, E) are targeted to this compartment and virions bud into the lumen once the nucleocapsid-wrapped genome interacts with them [1] . The pathway for egress is not well understood, but given the size of the virions, the exocytic compartments must be modified to accommodate the large cargo [2] . Several membrane proteins encoded by CoVs have ion channel activity (called viroporins) that might be required for efficient virus egress [3, 4] . The CoV E protein is such a viroporin [5] [6] [7] . We previously studied a recombinant infectious bronchitis virus (IBV) with an E protein containing a mutated transmembrane domain. Release of infectious virus is reduced for this mutant and particles that are released have aberrantly proteolyzed S proteins, explaining the reduction in infectivity [8, 9] . In addition, overexpression of the wild-type IBV E protein, but not the mutant E protein, resulted in reduced cargo trafficking and fragmentation of the Golgi complex [10] . We recently demonstrated that the wild-type IBV E protein neutralized the Golgi complex in infected and transfected cells, whereas the mutant E protein did not [11] . Surprisingly, the ion channel activity of IBV E was not required for Golgi neutralization and disruption, since these phenotypes correlated with a mutant form of E that is predominantly monomeric [12] . Neutralization of the Golgi was required to protect the S protein from aberrant proteolysis and is likely the cause of Golgi disruption. The reduced cargo trafficking we observed is apparently an acceptable compromise to promote release of infectious virus.

IBV is a gamma CoV, and human CoVs fall into the alpha and beta genera. The human CoVs that cause severe disease, including SARS CoV-1 and -2, and the Middle East respiratory syndrome (MERS) virus, are all beta-CoVs. Whether secretory pathway modifications are universal requirements for CoV egress is not known. A recent paper on mouse hepatitis virus (MHV), a beta CoV, showed that endo-lysosomal compartments were neutralized in infected cells [13] . The authors proposed a novel egress pathway through lysosomes. The viral protein required for neutralization of endo-lysosomes in MHV-infected cells is not yet known.

Interestingly, we found that the SARS CoV-1 E protein did not possess Golgi disruption activity when overexpressed in cells [9] . We therefore investigated one of the accessory proteins, ORF 3a, since an earlier publication reported alteration of Golgi morphology when the protein was transiently expressed [14] . The 3a protein is quite different in structure than the small, single membrane spanning E protein, with three membrane spans. However, it does have cation channel activity and has been implicated in virus egress [15] . The Enjuanes group has shown that SARS CoV-1 lacking either E or 3a was viable, but virus lacking both could not be recovered [16] . We report here that SARS CoV-1 3a has similar Golgi disrupting activity to the IBV E protein, and the 3a protein from SARS CoV-2 appears to have a similar function. However, the mechanism by which SARS CoV-1 3a induces disruption of Golgi function differs from that of IBV E because viroporin activity is required.

Vero (African green monkey kidney) cells (ATCC CCL81) were maintained in Dulbecco's modified minimal medium (Life Technologies) with 10% fetal bovine serum (Atlanta Biologicals) and normocin antibiotic (InVivoGen) at 37 o C with 5% CO 2 . They were routinely screened for mycoplasma contamination.

The 3a ORF from SARS CoV-1 (Tor2 strain) was originally obtained from the Institute for Genomic Research and subcloned into pBluescript (Stratagene) prior to transferring to pCAGGS-MCS [17] after PCR amplification with KpnI and XhoI restriction sites. SARS CoV-2 ORF 3a was subcloned from a plasmid kindly donated by Dr. Stephen Gould, Johns Hopkins Univ.) using KpnI and XhoI restriction sites. The pCAGGS plasmids encoding IBV E and SARS CoV-1 E have been previously described [10, 18] . The SARS CoV-1 3aY109A mutant was generated by QuikChange mutagenesis (Stratagene) using the forward primer 5'-GCGCAATTTTTGTACCTGGCGGCCTTGATATATTTTC-3' and the complementary reverse primer. Plasmids pCAGGS/SARS S and pCAGGS/SARS M were previously described [20] , as was the pCAGGS/VSVG plasmid [21] . The pGnT1-pHorin and TGN-pHlorin plasmids [22] were kindly provided by Dr. Yasuke Maeda (Osaka University, Japan).

Vero cells were plated at 2x10 5 per 35 mm dish on coverslips for indirect immunofluorescence microscopy, or 4x10 5 in 6 well dishes for trafficking experiments. For the Golgi luminal pH measurement, Vero cells were plated at 6x10 5 in 6 cm dishes. The following day, cells were transfected as follows. For immunofluorescence, 0.5 ug of SARS 3a or IBV E (with or without 0.2 ug of one of the pHlorin plasmids) by adding to 100 ul OPTI-MEM (Life Technologies) with diluted XtremeGene-9 (Roche), per the manufacturer's instructions. For the trafficking experiments, 0.5 ug of 3a or E was mixed with 0.5 ug SARS CoV S or VSV-G. For flow cytometry, 6 cm dishes were transfected with 1.5 ug 3a or E plasmid with 0.5 ug GnT1-pHlorin, using 300 ul OPTI-MEM and 6 ul XtremeGene-9. Additional cells were transfected with the pHlorin plasmid alone to produce the standard curve for pH measurement.

Rabbit polyclonal antibodies to IBV E, SARS CoV E, SARS CoV S and VSV-G were previously described [18] [19] [20] 23] . The SARS CoV-1 3a antibody was generated to a C-terminal peptide (CIYDEPTTTTSVPL-COOH) conjugated to KLH via the N-terminal cysteine residue and produced in rabbits by Covance Research Products. We determined specificity by immunoblotting and immunofluorescence using control and cells expressing SARS CoV-1 3a. SARS CoV-2 3a is identical in this epitope. Commercial primary antibodies were mouse anti-GM130 and mouse anti-p230 (BD Transduction Labs), and rabbit anti-giantin (Covance Research Products). Fluorescent secondary antibodies were from Life Technologies: Alexa Fluor 488 donkey anti-rabbit IgG, Alexa Fluor 568 donkey anti-mouse IgG, and Cy5 donkey anti-rabbit IgG.

Transfected cells were fixed at 18 h post-transfection. The protocol was exactly as described [11] . Images were acquired on an Axioskop microscope (Zeiss) equipped for epifluorescence using an Orca-03G CCD camera (Hamamatsu) and iVision software (BioVision Technologies). To quantify Golgi fragmentation, the area occupied by different Golgi resident proteins was determined. Images (acquired with the same parameters) were analyzed by outlining the stained Golgi elements after background subtraction using the trapezoid tool in ImageJ (Fiji), and the area occupied by each marker was quantified using the measure tool in the analysis menu. The total and integrated pixel intensity was also measured for each marker. The negative control was cells expressing IBV M, which is also Golgi targeted and the positive control was cells expressing IBV E. Analysis was performed in Prism GraphPad 8.0, with one-way ANOVA and post-hoc Tukey test. For all Golgi markers, including the peripheral membrane protein GM130, the total pixel intensities of stained elements in SARS CoV-1 3a-expressing cells were similar to those of cells expressing IBV M, suggesting the proteins were dispersed and not degraded.

Transfected cells were surface biotinylated to determine the level of cargo protein that had reached the plasma membrane. The lysates were also treated with endoglycosidase H (endo H) to determine the fraction that had moved past the medial Golgi by measuring oligosaccharide processing. For surface biotinylation, cells at 20 h post-transfection were rinsed in ice-cold PBS and then incubated at 0 o C for 30 min with Hank's buffered salt solution containing 0.5 ug/ml of EZlink NHS-sulfo biotin (Pierce), with rocking. The biotin was quenched by incubation in PBS with 10 mM glycine for 10 min at 0 o C, and cells were scraped, spun and lysed in 80 ul of 1% NP40, 150 mM NaCl, 10 mM Hepes pH 7.2 and 1x protease inhibitor cocktail (Sigma) on ice for 10 min, and clarified by centrifugation at 14K RPM for 10 min at 4 o C. Ten percent of the lysate was reserved for endoH digestion. This portion of the lysate was denatured in 1x denaturation buffer (New England Biolabs) with incubation at 85 o C for 15 min, diluted 2-fold in 1x G3 buffer (New England Biolabs) and incubated with 160 U endoglycosidase H (New England Biolabs) for 2h at 37 o C. Concentrated NuPAGE sample buffer (Life Technologies) was added, and the digests were resolved by SDS-PAGE as described below. Ten percent of the remaining lysate was reserved for input for surface levels and the rest was diluted 5-fold in lysis buffer and mixed with 50 ul of streptavidin-agarose (high-capacity, ThermoFisher). After rotation at 4 o C for 2h, biotinylated proteins were recovered from the beads after washing in lysis buffer by elution in gel sample buffer containing b-mercaptoethanol. Samples, including the endo H and surface input samples, were resolved on 4-12% NuPAGE gels (Life Technologies) in MES buffer. Following electrophoresis, proteins were transferred to PVDF for 90 min at 20 mA, and membranes were blocked with 5% nonfat milk in Tris-buffered saline (TBS) for 1h. Primary antibodies were incubated in Tris-buffered saline containing 5% nonfat milk and 0.05% Tween-20 overnight at 4 o C. After washing, secondary antibodies (IRDye 800 donkey anti-rabbit IgG, LiCOR) were applied for 1h at RT and after washing, blots were quantified on LiCOR Odyssey CLx system and Image Studio (LiCOR). Analysis was in Prism GraphPad 8.0. The percent of protein at the cell surface was calculated in relation to that in the input sample (10% of that used for the surface sample).

This was performed exactly as described [11] , using the medial Golgi pHlorin, GnT1-pHlorin. Transfected cells were incubated in 100 ug/ml cycloheximide (Sigma) for 60 min prior to analysis to chase newly synthesized proteins from the endoplasmic reticulum. A standard curve was prepared from cells expressing the pHlorin alone, incubated in the presence of 10 uM monensin (Sigma) and 10 uM nigericin (Sigma) at pH 5.5, 6.0, 6.5, 7.0 or 7.5 before flow cytometry. Samples were excited at 405 and 488 nm and emission was collected with filters between 500 and 550 nm and 515 to 545 nm respectively, in a LSRII flow cytometer (Becton Dickenson). Then the fluorescence of cells expressing IBV M, IBV E or SARS CoV-1 3a along with the GnT1-pHlorin were measured in the absence of ionophores. Data were collected and analyzed using FACS Diva 8.0 software and Excel. The emission ratios of GnT1-pHlorin in buffers of different pH in the presence of ionophores was used to generate a standard curve for calculating the Golgi luminal pH of cells expressing IBV M, IBV E and SARS CoV-1 3a. Although the pandemic prevented repeat of this single experiment, over 3500 cells were analyzed and earlier work demonstrated that the results are quite reproducible [11] .

To examine the effect of SARS CoV-1 3a overexpression on Golgi morphology, we transfected plasmids encoding the 3a protein (and IBV E and IBV M as positive and negative controls, respectively) into Vero cells. Of note, we did not observe any cell death (apoptotic or necrotic) in cells expressing 3a, as has been reported in other studies [24] [25] [26] . Perhaps initiation of cell death depends on higher levels of expression or on cell type. After 18 h, cells were fixed and stained for Golgi markers and the viral protein. Figure 1a shows the distribution of these proteins in transfected cells. SARS CoV-1 3a is transported past the Golgi to the plasma membrane, whereas IBV M and E are both retained in the Golgi region. Dispersion of Golgi complex proteins in cells expressing GnT1-pHlorin and the indicated viral protein was observed after staining with two Golgi markers: mouse anti-GM130 and rabbit anti-giantin (Figure 1b) . Transfected cells were identified by the GFP signal from the pHlorin and indicated by white arrows. The Golgi was dispersed in cells expressing SARS CoV-1 3a, similar to cells expressing IBV E. Cells expressing the IBV M protein served as a negative control, since this protein is also targeted to the Golgi complex but does not induce dispersion.

To quantify these results, the area occupied by stained Golgi elements was determined using ImageJ in cells transfected and imaged as in Figure 1b . GM130 is a peripheral cis-Golgi protein and giantin is an integral membrane protein of the medial-Golgi. Golgi dispersion in cells expressing SARS CoV-1 3a protein was not as extensive compared to that in cells expressing IBV E (Figure 2 ). This might be because SARS CoV-1 3a moves through the Golgi to post-Golgi compartments, while IBV E is tightly retained in the Golgi region, as seen in Figure 1a . To test this idea, we attempted to generate a 3a mutant that was retained in the Golgi by swapping out the cytoplamic tail with that of SARS CoV-1 E, which contains Golgi targeting information [19] . However, this mutant was retained in the endoplasmic reticulum (possibly misfolded) so was not useful in addressing this possibility. The peripheral Golgi protein GM130 showed greater dispersion than giantin, possibly reflecting the release of peripheral proteins before Golgi membrane elements are dispersed.

To determine if the morphological changes in the Golgi complex were accompanied by a reduced level of cargo traffic, we analyzed carbohydrate processing and surface levels of the vesicular stomatitis virus glycoprotein (VSV-G) in cells co-expressing SARS CoV-1 3a, IBV E or IBV M. The VSV-G protein is a commonly studied membrane protein with two N-linked oligosaccharides that are processed in the Golgi as the protein moves to the plasma membrane. At 20 h post-transfection, cells were first surface biotinylated using membrane impermeant NHS-sulfo-biotin. A portion of the lysate was reserved for digestion with endoglycosidase H (endo H) to determine the fraction of molecules that had been processed in the medial Golgi, and the biotinylated proteins in the remaining lysate were isolated on streptavidin-agarose. After SDS-PAGE and transfer to PVDF, VSV-G was identified by blotting with anti-VSV antibody. Representative blots are shown in Figures 3a and b , with quantitation of 3 experiments in Figure  3c . Both oligosachharide processing and surface expression for VSV-G were reduced in cells co-expressing SARS CoV-1 3a compared to the IBV M control, although not as strongly as in cells co-expressing IBV E. Reduced endo H processing and surface levels were also observed for cells co-expressing SARS CoV-1 S protein instead of VSV-G, to 46% and 28% of the negative control, respectively. The intermediate level of reduction of cargo trafficking compared to cells co-expressing IBV E paralleled the level of Golgi dispersion observed by indirect immunofluorescence microscopy, possibly reflecting the fact that the 3a protein is not retained in the Golgi like the IBV E protein.

We used flow cytometry to analyze the fluorescence of a Golgi-targeted luminal pHlorin molecule (GnT1-pHlorin) as described earlier [11] . The fluorescence of the GFP derivative called pHlorin is quenched at acidic pH. Vero cells expressing only the GnT1-pHlorin were used to generate a standard curve after incubation in buffers at fixed pH in the presence of ionophores. Then cells co-expressing GnT1-pHlorin and SARS CoV-1 3a, IBV E or IBV M were subjected to the same analysis in the absence of ionophores. The ratio of fluorescence emission spectra was measured as described in Materials and Methods Figure 4a) , and the pH of the Golgi lumen was calculated based on the standard curve. Although not as great a change as with IBV E, the pH of the Golgi lumen in cells expressing SARS CoV-1 3a was also increased (Figure 4b ). We concluded that the Golgi dispersion and reduction in cargo trafficking was likely a result of the increase in Golgi pH.

We previously showed that the Golgi dispersion and neutralization by IBV E did not appear to require its viroporin activity since these phenotypes correlated with a monomeric form of E that cannot form an ion channel [11] . We speculated that interaction with a host protein that required a specific sequence in the IBV E transmembrane domain was the mechanism for the observed phenotypes. To test if the SARS CoV-1 3a protein required viroporin activity for Golgi dispersion, we generated several 3a proteins with mutations that were reported to inactivate ion channel function [16] . First, Y91 and H93 in the second transmembrane were replaced with alanines. This mutant protein was poorly expressed however, so we did not pursue its analysis. Next, a point mutation in the third transmembrane domain, Y109A, was generated. This protein was expressed as well as the wild-type protein and was distributed in a similar cellular pattern (Figure 5a ). Golgi dispersion was less evident in cells expressing 3aY109A compared to wildtype protein. Quantification showed that the mutant protein did not disrupt Golgi morphology to the same extent as the wild-type 3a protein (Figure 5b) . The same was found for cargo trafficking: for VSV-G endo H resistance, 3aYA was 66% of the negative control, and for surface, 88% (compare to Figure 3) . Thus, unlike the IBV E protein, the SARS CoV-1 3a protein may disrupt secretory compartments directly through ion channel activity.

After the emergence of SARS CoV-2 that caused the COVID-19 pandemic, we were curious if the SARS CoV-2 E or 3a proteins might have similar effects on the Golgi complex. In cells overexpressing SARS CoV-2 E, we saw no morphological effects on the Golgi. However, overexpression of the SARS CoV-2 3a protein did induce alterations in Golgi morphology similar to those in cells expressing SARS CoV-1 3a ( Figure 6 ). Golgi marker dispersion was observed for both the cis-Golgi GM130 protein and the trans-Golgi p230 protein. Even though the amino acid identity of SARS CoV-1 and -2 3a is only 73% (85% similar), the residues that are important for ion channel activity are conserved. Thus, it is likely that the mechanism for Golgi disruption for SARS CoV-2 is similar to that for SARS CoV-1.

The SARS CoV-1 3a protein has been implicated in virus pathogenicity [16] , possibly through inflammasome activation and/or induction of cell death [24] [25] [26] [27] . Ion channel activity is important for pathogenicity [16] . The SARS CoV-2 3a protein was recently reported to block autophagosome fusion with lysosomes and impair lysosome function, but interestingly SARS CoV-1 3a protein did not have this activity [28] . Whether this difference in SARS CoV-1 and -2 3a protein contributes to differences in infectivity is not yet known. Not all coronaviruses encode a 3a-like protein; a recent preprint reports that only pathogenic human coronaviruses that have their closest ancestors in bats have the protein, including SARS CoV-1, Middle East respiratory syndrome (MERS) virus and SARS CoV-2 [29] .

We show here that the SARS CoV-1 3a protein disrupts Golgi morphology and cargo trafficking through the Golgi complex. We previously studied this phenotype induced by IBV, a gamma-coronavirus, and showed it was due to the E protein. IBV does not encode a 3a-like viroporin. However, overexpression of the SARS CoV-1 E protein did not disrupt the Golgi [9] , leading us to investigate the 3a protein. The Golgi disruption in cells expressing SARS CoV-1 3a was not as dramatic as that in cells expressing the IBV E protein. We believe that this is due to the lack of retention of the 3a protein in the Golgi like the IBV E protein. The dispersion of Golgi markers, reduction in cargo trafficking and modest neutralization of the Golgi lumen is likely due to the transient presence of the 3a protein in this compartment. We attempted to construct a 3a protein that was retained in the Golgi to test this idea, but the chimeric protein may have been misfolded because it was not transported out of the endoplasmic reticulum and thus could not be used to address this possibility. We also showed that expression of SARS CoV-2 3a disrupts Golgi morphology, suggesting it may have similar properties to SARS CoV-1 3a.

A monomeric form of IBV E is responsible for the Golgi phenotypes and thus cannot be due to its viroporin function [11] . To test if SARS CoV-1 3a viroporin activity was required for Golgi disruption, we tested a mutant (Y109A) that was previously shown to eliminate ion channel activity in vitro [16] . Golgi dispersion in cells expressing this mutant protein was reduced relative to the wild-type protein, but not abrogated. It is possible that this single amino acid change is not enough to eliminate channel activity in cells. A recent cryo electron microscopy structure of SARS CoV-2 3a protein suggests that the main channel for ion transport is formed by transmembrane domains 1 and 2, whereas Y109 is in transmembrane domain 3 and may contact the neighboring dimer [29] . This may also be the case for SARS CoV-1 3a, since the proteins are relatively conserved. If so, this could explain why the Y109A mutant was not completely inactive. We also generated a 3a mutant with two substitutions in the second transmembrane domain (Y91 and H93 changed to alanines), which also lacks ion channel activity in vitro [16] . However, the protein was poorly expressed so was not used in our analyses.

Collapse of pH gradients in cellular organelles is known to disrupt membrane traffic and alter the composition and morphology of organelles [30, 31] . The disruption of Golgi function observed in cells expressing SARS CoV-1 3a (and IBV E) are likely due to neutralization of the Golgi complex. The mechanism of neutralization of acidic compartments by SARS CoV-1 3a could involve direct viroporin-induced collapse of potassium gradients across organellar membranes. Calcium may also be transported by the 3a channel [29] , which could affect luminal proton concentrations directly or indirectly. For IBV E, we proposed that the monomeric form interacts with a host protein required for acidification (directly or indirectly) and inhibits its function [11] . Since IBV E is tightly retained in the early Golgi, this mechanism may make sense if downstream compartments need to be neutralized. By contrast, the SARS CoV-1 3a protein is trafficked to the plasma membrane and endo-lysosomal compartments so it could act directly to neutralize acidic compartments throughout the endomembrane system. It is interesting that a similar phenotype is present for two different coronaviruses but depends on different viral proteins and apparently different mechanisms. This suggests that neutralization of acidic compartments is an important feature of coronavirus-infected cells.

For a virus that assembles by budding into an early Golgi compartment and then must egress from the cell, reduction in cargo trafficking is unexpected. For IBV, neutralization protects the S protein from aberrant proteolysis as virions egress, keeping virus infectious [11] . Thus, the reduction in the rate of virus release may be an acceptable compromise. Neutralization of endosomes or lysosomes could also impact antigen presentation and contribute to immune evasion, as recently proposed [13] .

One limitation of our study is that we only examined cells expressing the viral proteins from cDNA. In the future, it will be important to measure the luminal pH of Golgi, endosomes and lysosomes in infected cells. Our previous results with IBV E suggest that the phenotypes in cells overexpressing the protein might be exaggerated but accurately reflect the function in infected cells [7, 11, 12] . Proteolytic processing of S in both SARS CoV-1 and -2 infected cells when the 3a protein is compromised will also need to be assessed. Importantly, specific inhibition of 3a channel function with repurposed or new drugs may provide additional treatments for SARS, MERS and COVID-19 [3, 32] . -1 3a) , 79 (3aY109A) and 39 (IBVE). Significance by one-way ANOVA and post-hoc Tukey test: *** p <0.001, * p = 0.01-0.05, ns, non-significant. Figure 6 . SARS CoV-2 3a protein alters Golgi morphology. Vero cells expressing SARS CoV-2 3a and GnT1-pHlorin were stained with mouse anti-GM130 or mouse anti-p230 (both red in merge) and rabbit anti-SARS 3a (green in merge) along with Hoescht 33342 (blue in merge). Both Golgi markers are dispersed to similar extents as in cells expressing SARS CoV-1 3a. The quantification of Golgi area in the lower panels was from two independent experiments, and the Golgi area in 3a-expressing cells was compared to that in neighboring non-transfected cells. Violin plots show median (dashed line) and quartiles (dotted lines). N= 23 (GM130), 26 (p230), 32 (non-transfected). Note the different scales when comparing GnT1-pHlorin. Significance by one-way ANOVA and post-hoc Tukey test: *** p <0.001, ** p <0.05, ns, non-significant.

Coronavirus structural proteins and virus assembly

Accommodation of large cargo within Golgi cisternae

Coronavirus Proteins as Ion Channels: Current and Potential Research

Viral proteins function as ion channels

SARS coronavirus E protein forms cation-selective ion channels

Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome

The coronavirus E protein: assembly and beyond

The transmembrane domain of the infectious bronchitis virus E protein is required for efficient virus release

A single polar residue and distinct membrane topologies impact the function of the infectious bronchitis coronavirus E protein

The hydrophobic domain of infectious bronchitis virus E protein alters the host secretory pathway and is important for release of infectious virus

The Infectious Bronchitis Coronavirus Envelope Protein Alters Golgi pH To Protect the Spike Protein and Promote the Release of Infectious Virus

A Coronavirus E Protein is Present in Two Distinct Pools with Different Effects on Assembly and the Secretory Pathway

Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway

The open reading frame 3a protein of severe acute respiratory syndrome-associated coronavirus promotes membrane rearrangement and cell death

Severe acute respiratory syndromeassociated coronavirus 3a protein forms an ion channel and modulates virus release

Role of Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and Pathogenesis

Efficient selection for high-expression transfectants with a novel eukaryotic vector

Infectious bronchitis virus E protein is targeted to the Golgi complex and directs release of virus-like particles

Identification of a Golgi complex-targeting signal in the cytoplasmic tail of the severe acute respiratory syndrome coronavirus envelope protein

The cytoplasmic tail of the severe acute respiratory syndrome coronavirus spike protein contains a novel endoplasmic reticulum retrieval signal that binds COPI and promotes interaction with membrane protein

A single tyrosine in the severe acute respiratory syndrome coronavirus membrane protein cytoplasmic tail is important for efficient interaction with spike protein

GPHR is a novel anion channel critical for acidification and functions of the Golgi apparatus

Oligomerization of a membrane protein correlates with its retention in the Golgi complex

The 3a Protein of SARScoronavirus Induces Apoptosis in Vero E6 Cells

SARS-Coronavirus Open Reading Frame-3a drives multimodal necrotic cell death

The ion channel activity of the SARScoronavirus 3a protein is linked to its pro-apoptotic function

Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC

ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated assembly of the SNARE complex required for autolysosome formation

Cryo-EM structure of the SARS-CoV-2 3a ion channel in lipid nanodiscs. bioRxiv : the preprint server for biology

Acidification and protein traffic

Golgi-disturbing agents

Kaempferol derivatives as antiviral drugs against the 3a channel protein of coronavirus

We thank Jason Westerbeck and Trisha Nilles for assistance with the flow cytometry, Stephen Gould and Chenxu Guo for the plasmids encoding SARS CoV-2 E and 3a and Yusuke Maeda for the pHlorin plasmids.

The authors declare no conflict of interest.